#PortfolioNews I We’re excited to share that our #portfolio company #Anacond Biomed has enrolled the first U.S. patient in its ATHENA trial.

🎯 Developing next-generation #neurothrombectomy devices for acute ischemic #stroke

👉 buff.ly/vXEDmrK

#vc #Spain #Medtech